PSNL
Personalis, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$15.88
+1.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.21x
- Price / sales
- 24.34x
- Price / cash flow
- -18.38x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 21.84x
- EV / EBITDA
- -15.65x
- EV / EBIT
- -13.31x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026